Emma Murray

ID: 1b839340-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

FDA Approves New Biologic Cancer Treatments

Big Molecule Watch · December 16, 2024

Daewoong and Celltrion to Market Denosumab Biosimilar in Korea

Big Molecule Watch · November 7, 2024

FDA Approves Samsung’s Eculizumab Biosimilar

Big Molecule Watch · July 25, 2024

Alexion’s Preliminary Injunction Motion Denied in Eculizumab BPCIA Litigation Against Samsung Bioepis

Big Molecule Watch · May 14, 2024

FDA Approves New Indication for AstraZeneca and Daiichi Sankyo’s Cancer Drug ENHERTU

Big Molecule Watch · April 9, 2024